DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Neoptolemos JP, Palmer DH, Ghaneh P. et al.
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial.
Lancet 2017;
389: 1011-1024
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.